Global Colon Cancer Patient Insights and Epidemiology - 2016

  • ID: 3692177
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Colon Cancer Patient Insights and Epidemiology – 2016, provides insights into total Colon Cancer patients on drug therapies in top 7 markets, Colon Cancer treatable patients, and Colon Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Colon Cancer specialists, oncologists, and Colon Cancer patients to identify the Colon Cancer patients in top 7 markets who were treated by drug therapies. The research also identifies total Colon Cancer patients’ on drug therapies by Colon Cancer stages.
Colon cancer patients were given chemotherapies as a part of their treatment. This study accurately determines and forecast Colon Cancer patients who were on drug therapies in a given year. This research also provides insights into Colon Cancer epidemiology including Colon Cancer incidence and Colon Cancer prevalence by Colon Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Colon Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Colon Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Colon Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Colon Cancer Patients on drug therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Colon Cancer market potential, Colon Cancer drug therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Colon Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on drug therapies
3. Colon Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on drug therapies
4. Colon Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on drug therapies
5. Colon Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on drug therapies
6. Colon Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on drug therapies
7. Colon Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on drug therapies
8. Colon Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on drug therapies
9. Colon Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on drug therapies
10. Glossary

1. Colon Cancer Incidence by Stages, Global, 2010 - 2025
2. Colon Cancer Prevalence by Stages, Global, 2010 - 2025
3. Colon Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Colon Cancer Patients on drug therapies by Stages, Global, 2010 – 2025
5. Colon Cancer Incidence by Stages, Germany, 2010 - 2025
6. Colon Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Colon Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Colon Cancer Patients on drug therapies by Stages, Germany, 2010 - 2025
9. Colon Cancer Incidence by Stages, France, 2010 - 2025
10. Colon Cancer Prevalence by Stages, France, 2010 - 2025
11. Colon Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Colon Cancer Patients on drug therapies by Stages, France, 2010 - 2025
13. Colon Cancer Incidence by Stages, Italy, 2010 - 2025
14. Colon Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Colon Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Colon Cancer Patients on drug therapies by Stages, Italy, 2010 - 2025
17. Colon Cancer Incidence by Stages, Spain, 2010 - 2025
18. Colon Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Colon Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Colon Cancer Patients on drug therapies by Stages, Spain, 2010 - 2025
21. Colon Cancer Incidence by Stages, UK, 2010 - 2025
22. Colon Cancer Prevalence by Stages, UK, 2010 - 2025
23. Colon Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Colon Cancer Patients on drug therapies by Stages, UK, 2010 – 2025
25. Colon Cancer Incidence by Stages, Japan, 2010 - 2025
26. Colon Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Colon Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Colon Cancer Patients on drug therapies by Stages, Japan, 2010 – 2025
29. Colon Cancer Incidence by Stages, US, 2010 - 2025
30. Colon Cancer Prevalence by Stages, US, 2010 - 2025
31. Colon Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Colon Cancer Patients on drug therapies by Stages, US, 2010 - 2025

1. Colon Cancer Incidence, Global, 2010 – 2025
2. Colon Cancer Incidence – Stage I, Global, 2010 – 2025
3. Colon Cancer Incidence – Stage II, Global, 2010 - 2025
4. Colon Cancer Incidence – Stage III, Global, 2010 - 2025
5. Colon Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Colon Cancer Prevalence, Global, 2010 - 2025
7. Colon Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Colon Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Colon Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Colon Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Colon Cancer Treatable Patients, Global, 2010 - 2025
12. Colon Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Colon Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Colon Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Colon Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Colon Cancer Patients on drug therapies, Global, 2010 - 2025
17. Total Colon Cancer Patients on drug therapies – Stage I, Global, 2010 – 2025
18. Total Colon Cancer Patients on drug therapies – Stage II, Global, 2010 – 2025
19. Total Colon Cancer Patients on drug therapies – Stage III, Global, 2010 – 2025
20. Total Colon Cancer Patients on drug therapies – Stage IV, Global, 2010 – 2025
21. Colon Cancer Incidence by Stages, Germany, 2010 – 2025
22. Colon Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Colon Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Colon Cancer Patients on drug therapies, Germany, 2010 - 2015
25. Colon Cancer Incidence by Stages, France, 2010 – 2025
26. Colon Cancer Prevalence by Stages, France, 2010 – 2025
27. Colon Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Colon Cancer Patients on drug therapies, France, 2010 – 2025
29. Colon Cancer Incidence by Stages, Italy, 2010 – 2025
30. Colon Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Colon Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Colon Cancer Patients on drug therapies, Italy, 2010 – 2025
33. Colon Cancer Incidence by Stages, Spain, 2010 – 2025
34. Colon Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Colon Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Colon Cancer Patients on drug therapies, Spain, 2010 - 2015
37. Colon Cancer Incidence by Stages, UK, 2010 – 2025
38. Colon Cancer Prevalence by Stages, UK, 2010 – 2025
39. Colon Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Colon Cancer Patients on drug therapies, UK, 2010 – 2025
41. Colon Cancer Incidence by Stages, Japan, 2010 – 2025
42. Colon Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Colon Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Colon Cancer Patients on drug therapies, Japan, 2010 – 2025
45. Colon Cancer Incidence by Stages, US, 2010 – 2025
46. Colon Cancer Prevalence by Stages, US, 2010 – 2025
47. Colon Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Colon Cancer Patients on drug therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll